Edition:
United States

People: Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

1.70USD
4:00pm EDT
Change (% chg)

$0.02 (+1.19%)
Prev Close
$1.68
Open
$1.65
Day's High
$1.73
Day's Low
$1.62
Volume
72,502
Avg. Vol
115,301
52-wk High
$1.81
52-wk Low
$0.51

Mosquera, Bernardino 

Dr. Bernardino Mosquera, M.D. has been appointed as Vice President - Clinical Operations of Catalyst Pharmaceutical Partners, Inc. effective March 5, 2013. For the last three years, Dr. Mosquera managed his own clinical research consulting company. As an independent consultant, Dr. Mosquera was involved in trials for Alzheimer’s, Parkinson’s, and stroke medications for a multinational pharmaceutical company and several biotech companies. Prior to his time as an independent consultant, for approximately five years Dr. Mosquera worked first with Amgen and later as a dedicated contractor for Amgen on a number of Phase 3 trials in the oncology area. Prior to his time with Amgen, Dr. Mosquera worked with Kos Pharmaceuticals where he was involved in all aspects of clinical trial management for two Phase 3 trials, where he was responsible for CRO selection, site selection, vendor management, creation of study documents, IRB submissions, trial management, and CRA management. Dr. Mosquera received his medical degree from the Central University of Venezuela, School of Medicine. He also holds a master’s degree in public health from the University of South Florida.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --